Arthneeti
VO

Valiant Organics Ltd

Q1 FY26Chemicals & Petrochemicals

Valiant Organics Ltd Q1 FY26 Results & Presentation Highlights: Revenue, Margins & Order Book

Q1 FY26 investor presentation: what the company reported on revenue, margins and projects.

Price₹411
Market cap₹1.2K Cr
P/E23.7
Updated24 Sept 2026
Read4 min read

Based on Valiant Organics Ltd's Q1 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.

The short version

The presentation provides annual financial figures rather than quarterly data. EBITDA for FY25 is INR 54 Cr (from page 10, PAT is shown but EBITDA 54 Cr is deduced from PAT margin and EBITDA margin trends). - EBITDA margin is reported as 7.47% for FY25 (page 10). - Operating Revenue for FY25 is INR 719 Cr (page 10). - PAT for FY25 is INR 38 Cr (page 10). - PAT margin for FY25 is 5.28% (page 10). - Year-on-year changes from FY24 to FY25 show EBITDA margin increase from 5.28% to 7.47% and PAT margin increase from about 1.26% to 5.28% (page 10). - No explicit margin outlook (future guidance) is stated in the presentation.

From Valiant Organics Ltd's Q1 FY26 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • The presentation provides annual financial figures rather than quarterly data.
  • Operating revenue for FY22 to FY25:
  • FY22: INR 1,153 Cr
  • FY23: INR 1,052 Cr
  • FY24: INR 723 Cr
  • FY25: INR 719 Cr
  • Year-on-year revenue change:
  • FY23 over FY22: -8.77% (approximate drop from 1153 to 1052 Cr)
  • FY24 over FY23: -31.27% (approximate drop from 1052 to 723 Cr)
  • FY25 over FY24: -0.55% (approximate drop from 723 to 719 Cr)
  • No explicit quarterly sales or volume figures reported.
  • No explicit forward-looking statements or outlook for revenue or volume growth in the presentation.

2 more points management made on revenue & sales performance

Profitability & Margins

See what Valiant Organics Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

The presentation does not explicitly mention any ongoing or planned capex, capacity expansion, or new plant/project details, including amounts, status, or timelines. It focuses primarily on: - Current manufacturing footprint: 6 units across 5 locations with total production capacity of 70,000 TPA. - Product and chemistry breakdown. - Financial highlights and business strengths. No specific future capital expenditure, expansion projects, or timelines are detailed in the provided slides.

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

5x potential
1Shiv Texchem Ltd
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Valiant Organics Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The investor presentation does not explicitly report any figures or details related to order book, order inflow, or pending orders. - The presentation primarily provides an overview of the company’s financial performance (revenue, EBITDA, PAT, margins, ROCE, ROE), manufacturing footprint, product basket, and company strengths. - No specific data or commentary concerning current order book size, recent order inflow, or pending orders is mentioned in the slides. - The key financial and operational metrics focus on historical and projected financial results, capacities, and revenue break-up by chemistry and industry, without reference to order backlog or order inflow status.

Valiant Organics Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹218 Cr, net profit ₹15 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Valiant Organics Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Balaji Amines Ltd (Q1 FY26)

    Q1FY26 consolidated revenue from operations: ₹367 crore, up 2% quarter-on-quarter from ₹361 crore in Q4FY25, but down 7% year-on-year from ₹393 crore in Q1FY25…

  • Linde India Ltd (Q1 FY26)

    Net Revenue for FY ended Mar’25 was INR 24,854 million, down 10.2% (–2,833 million) YoY from INR 27,687 million. Key investor presentation takeaways from Linde

  • Vidhi Specialty Food Ingredients Ltd (Q1 FY26)

    87.9 Crores . Key investor presentation takeaways from Vidhi Specialty Food Ingredients Ltd's Q1 FY26 investor presentation — and how it ranks against sector pe

  • Chemcon Speciality Chemicals Ltd (Q1 FY26)

    Q1 FY26 revenue from operations: ₹53.5 Cr, up 18% YoY from ₹45.5 Cr in Q1 FY25 (Page 7 & 6). Key investor presentation takeaways from Chemcon Speciality Chemica

Compare:vs Solar Industries India Ltdvs Pidilite Industries Ltdvs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Valiant Organics Ltd Q1 FY26 results?

The presentation provides annual financial figures rather than quarterly data. EBITDA for FY25 is INR 54 Cr (from page 10, PAT is shown but EBITDA 54 Cr is deduced from PAT margin and EBITDA margin trends). - EBITDA margin is reported as 7.47% for FY25 (page 10). - Operating Revenue for FY25 is INR 719 Cr (page 10). - PAT for FY25 is INR 38 Cr (page 10). - PAT margin for FY25 is 5.28% (page 10). - Year-on-year changes from FY24 to FY25 show EBITDA margin increase from 5.28% to 7.47% and PAT margin increase from about 1.26% to 5.28% (page 10). - No explicit margin outlook (future guidance) is stated in the presentation.

What is Valiant Organics Ltd share price analysis?

Valiant Organics Ltd currently shows a neutral. The stock trades at a P/E of 23.7 with a market cap of ₹1,196 Cr. Investors should review the full earnings analysis for detailed insights.

Is Valiant Organics Ltd planning capital expenditure?

The presentation does not explicitly mention any ongoing or planned capex, capacity expansion, or new plant/project details, including amounts, status, or timelines.

Keep Valiant Organics Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.